Mindfulness practice for protecting mental health during the COVID-19 pandemic.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
28 05 2021
Historique:
received: 04 07 2020
accepted: 18 05 2021
revised: 09 05 2021
entrez: 29 5 2021
pubmed: 30 5 2021
medline: 22 6 2021
Statut: epublish

Résumé

Emerging evidence shows that the coronavirus disease 2019 (COVID-19) pandemic is negatively affecting mental health around the globe. Interventions to alleviate the psychological impact of the pandemic are urgently needed. Whether mindfulness practice may protect against the harmful emotional effects of a pandemic crisis remains hitherto unknown. We investigated the influence of mindfulness training on mental health during the COVID-19 outbreak in China. We hypothesized that mindfulness practitioners might manifest less pandemic-related distress, depression, anxiety, and stress than non-practitioners and that more frequent practice would be associated with an improvement in mental health during the pandemic. Therefore, we assessed pandemic-related distress and symptoms of depression, anxiety, and stress, as well as the frequency of meditation practice at the peak of new infections (Feb 4-5; N = 673) and three weeks later (Feb 29-30; N = 521) in mindfulness practitioners via online questionnaires. Self-reported symptoms were also collected from non-practitioners at peak time only (N = 1550). We found lower scores of pandemic-related distress in mindfulness practitioners compared to non-practitioners. In general, older participants showed fewer symptoms of depression and anxiety. In younger practitioners, pandemic-related distress decreased from peak to follow-up. Importantly, increased mindfulness training during the preceding two weeks was associated with lower scores of depression and anxiety at both assessments. Likewise, practice frequency predicted individual improvement in scores of depression, anxiety, and stress at follow-up. Our results indicate that mindfulness meditation might be a viable low-cost intervention to mitigate the psychological impact of the COVID-19 crisis and future pandemics.

Identifiants

pubmed: 34050125
doi: 10.1038/s41398-021-01459-8
pii: 10.1038/s41398-021-01459-8
pmc: PMC8160402
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

329

Subventions

Organisme : Science and Technology Commission of Shanghai Municipality (Shanghai Municipal Science and Technology Commission)
ID : 2018SHZDZX01
Organisme : Science and Technology Commission of Shanghai Municipality (Shanghai Municipal Science and Technology Commission)
ID : 2018SHZDZX01
Organisme : National Natural Science Foundation of China (National Science Foundation of China)
ID : NSFC91630314
Organisme : National Natural Science Foundation of China (National Science Foundation of China)
ID : NSFC91630314
Organisme : Shanghai Science and Technology Development Foundation (Shanghai Science and Technology Development Fund)
ID : 16JC1420402
Organisme : Shanghai Science and Technology Development Foundation (Shanghai Science and Technology Development Fund)
ID : 16JC1420402

Références

Am J Psychiatry. 1983 Jan;140(1):41-6
pubmed: 6847983
PLoS One. 2017 Aug 23;12(8):e0182145
pubmed: 28832594
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 May;56(5-6):733-9
pubmed: 23703492
JAMA Psychiatry. 2016 Jun 1;73(6):565-74
pubmed: 27119968
Neuropsychopharmacology. 2021 Jan;46(1):217-218
pubmed: 32792683
Neurosci Biobehav Rev. 2016 Jun;65:208-28
pubmed: 27032724
Brain Behav Immun. 2020 Jul;87:124-125
pubmed: 32360603
Annu Rev Psychol. 1997;48:191-214
pubmed: 9046559
Neuroimage. 2018 Nov 1;181:301-313
pubmed: 29990584
Clin Psychol Rev. 2013 Aug;33(6):763-71
pubmed: 23796855
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Behav Res Methods. 2009 Nov;41(4):1149-60
pubmed: 19897823
Behav Res Ther. 2017 Aug;95:29-41
pubmed: 28527330
Acta Neuropsychiatr. 2020 Oct;32(5):274-276
pubmed: 32434604
JAMA Netw Open. 2020 May 1;3(5):e2010185
pubmed: 32463467
Psychol Bull. 2008 Mar;134(2):163-206
pubmed: 18298268
Chronic Stress (Thousand Oaks). 2017 Feb;1:
pubmed: 28840198
J Consult Clin Psychol. 2016 May;84(5):427-37
pubmed: 26950097
Behav Ther. 2016 Nov;47(6):886-905
pubmed: 27993339
Psychiatr Serv. 2008 Dec;59(12):1383-90
pubmed: 19033164
Cogn Behav Ther. 2019 Nov;48(6):445-462
pubmed: 30732534
J Psychiatr Res. 2021 Feb;134:69-77
pubmed: 33360865
Lancet Psychiatry. 2020 Apr;7(4):300-302
pubmed: 32085840
Soc Psychiatry Psychiatr Epidemiol. 2016 Mar;51(3):339-48
pubmed: 26843197
JAMA Intern Med. 2014 Mar;174(3):357-68
pubmed: 24395196
Am Psychol. 2015 Oct;70(7):632-58
pubmed: 26436313
Am Psychol. 2015 Oct;70(7):593-620
pubmed: 26436311
Brain Cogn. 2016 Oct;108:32-41
pubmed: 27429096
Clin Psychol Rev. 2015 Apr;37:26-39
pubmed: 25748559
Psychol Bull. 2014 May;140(3):774-815
pubmed: 24417575
Lancet Public Health. 2020 Jan;5(1):e62-e70
pubmed: 31910981
Int J Environ Res Public Health. 2021 Feb 16;18(4):
pubmed: 33669453
Clin Psychol Rev. 2016 Apr;45:102-14
pubmed: 27111302
Lancet Psychiatry. 2020 Jun;7(6):547-560
pubmed: 32304649
Can J Psychiatry. 2012 Feb;57(2):70-7
pubmed: 22340146
Br J Psychiatry. 2012 May;200(5):359-60
pubmed: 22550328
Nat Rev Neurosci. 2015 Apr;16(4):213-25
pubmed: 25783612
Gen Psychiatr. 2020 Mar 6;33(2):e100213
pubmed: 32215365
Emotion. 2010 Feb;10(1):83-91
pubmed: 20141305
J Psychosom Res. 2015 Jun;78(6):519-28
pubmed: 25818837
Psychol Inq. 2015 Oct 1;26(4):293-314
pubmed: 27087765
Front Psychiatry. 2020 Aug 07;11:790
pubmed: 32848952
J Consult Clin Psychol. 2010 Apr;78(2):169-83
pubmed: 20350028
Front Psychol. 2017 Mar 06;8:220
pubmed: 28321194
Br J Psychiatry. 2016 Apr;208(4):330-6
pubmed: 26892850
Lancet Public Health. 2018 Feb;3(2):e72-e81
pubmed: 29422189
Soc Psychiatry Psychiatr Epidemiol. 2021 Jan;56(1):1-11
pubmed: 33245379
Clin Psychol Rev. 2013 Feb;33(1):82-96
pubmed: 23142788
Biol Psychiatry. 2019 Nov 1;86(9):693-702
pubmed: 31303261
J Anxiety Disord. 2020 Mar;70:102196
pubmed: 32078967
Transl Psychiatry. 2020 Aug 20;10(1):291
pubmed: 32820171
Int J Environ Res Public Health. 2020 Mar 06;17(5):
pubmed: 32155789
Emotion. 2010 Feb;10(1):54-64
pubmed: 20141302
Annu Rev Psychol. 2015 Jan 3;66:487-518
pubmed: 25293689
J Anxiety Disord. 2020 Aug;74:102258
pubmed: 32569905
Psychiatry Res. 2020 Jan 16;285:112794
pubmed: 32078885
Mindfulness (N Y). 2013;4:246-254
pubmed: 23956806
Annu Rev Clin Psychol. 2019 May 7;15:285-316
pubmed: 30525995
JAMA Netw Open. 2020 Mar 2;3(3):e203976
pubmed: 32202646
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
Front Hum Neurosci. 2012 Sep 19;6:257
pubmed: 23049507
Lancet Psychiatry. 2020 Mar;7(3):228-229
pubmed: 32032543

Auteurs

Julie Lei Zhu (JL)

Fanhai International School of Finance, Fudan University, Shanghai, China.

Rasmus Schülke (R)

Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, China.

Deniz Vatansever (D)

Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, China.

Dayou Xi (D)

School of Economics, Fudan University, Shanghai, China.

Junjie Yan (J)

Pure Awareness Research Institute, Shanghai, China.

Hanqing Zhao (H)

Pure Awareness Research Institute, Shanghai, China.

Xiaohua Xie (X)

Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, China.

Jianfeng Feng (J)

Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, China.

Mark Yuting Chen (MY)

Pure Awareness Research Institute, Shanghai, China.

Barbara Jacquelyn Sahakian (BJ)

Behavioural and Clinical Neurosciences Institute, Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom. bjs1001@cam.ac.uk.

Shouyan Wang (S)

Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, China. shouyan@fudan.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH